Enners, Salka

Referentin für Pharmakoepidemiologie [bis 2023], Apothekerin, Deutsches Arzneiprüfungsinstitut e. V. (DAPI) [bis 2023], Berlin

Publikationen

• Increased Demand for Pharmaceutical Drugs Containing Potassium Iodide In Connection with the Russia-Ukraine Conflict
• Auszeichnung als Top Downloaded Article 2021-2022
• Auszeichnung als Top Cited Article 2021-2022
• Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
• Masterthesis - Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave
• Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
• Verordnungsqualität oraler Fluorchinolone in den deutschen Bundesländern 2014 bis 2019
• Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave
• Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave
• Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019
• Infliximab And Etanercept Biosimilars And Originators: Learnings From Regional Market Dynamics In Germany
• Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
• Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
• “Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription
• Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany
• Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide